Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 18/20 | 0.81 |
| ▸ | PPARG | P37231 | 13/20 | 0.81 |
| ▸ | PPARD | Q03181 | 7/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5365635 | 1.00 | PPARA (0.81) | PPARAPPARGPPARD | |
| SCHEMBL5999342 | 1.00 | PPARA (0.81) | PPARAPPARGPPARD | |
| SCHEMBL5992773 | 0.91 | PPARA (0.67) | PPARAPPARGPPARD | |
| Tesaglitazar SCHEMBL16594 | 0.90 | PPARA (1.00) | PPARAPPARGPPARD | |
| Tesaglitazar SCHEMBL600880 | 0.90 | PPARA (1.00) | PPARAPPARGPPARD | |
| SCHEMBL5368994 | 0.90 | PPARA (1.00) | PPARAPPARGPPARD | |
| Tesaglitazar SCHEMBL3162078 | 0.90 | PPARA (1.00) | PPARAPPARGPPARD | |
| Tesaglitazar SCHEMBL13602606 | 0.90 | PPARA (1.00) | PPARAPPARGPPARD | |
| SCHEMBL5991979 | 0.90 | PPARG (0.66) | PPARAPPARGPPARD | |
| SCHEMBL7238281 | 0.89 | PPARA (0.68) | PPARAPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060173204-A1 | New 3-aryl propionic acid derivatives and analogs | ANDERSSON KJELL | 2006-08-03 | — | — | US | disclosed |
| US-20060040979-A1 | 3-Aryl-2-hydroxypropionic acid derivative I | ANDERSSON KJELL | 2006-02-23 | — | — | US | disclosed |
| JP-2004346079-A | NEW 3-ARYLPROPIONIC ACID DERIVATIVES AND ANALOGS | ASTRAZENECA AB | 2004-12-09 | — | — | JP | disclosed |
| US-20040229946-A1 | New 3-aryl-2-hydroxypropionic acid derivative I | ANDERSSON KJELL (SE) | 2004-11-18 | — | — | US | disclosed |
| US-20040229949-A1 | New 3-aryl propionic acid derivatives and analogs | ANDERSSON KJELL (SE) | 2004-11-18 | — | — | US | disclosed |
| EP-1237857-B1 | NEW PHENALKYLOXY-PHENYL DERIVATIVES | ASTRAZENECA AB (SE) | 2004-06-30 | — | — | EP | disclosed |
| US-6660879-B2 | Use of the compound in clinical conditions associated with insulin resistance. | ASTRAZENECA AB (SE) | 2003-12-09 | — | — | US | disclosed |
| US-6630509-B2 | Pharmaceutical medication associated with insulin resistance; patient with prophylaxis conditions having reduced sensitivity to insulin | ASTRAZENECA AB (SE) | 2003-10-07 | — | — | US | disclosed |
| US-6630600-B1 | Intermediate for their manufacture, pharmaceutical preparations containing them and the use of the compounds in clinical conditions associated with insulin resistance. | ASTRAZENECA AB (SE) | 2003-10-07 | — | — | US | disclosed |
| EP-1084102-B1 | NEW 3-ARYL PROPIONIC ACID DERIVATIVES AND ANALOGS | ASTRAZENECA AB (SE) | 2003-10-01 | — | — | EP | disclosed |
| US-20030027859-A1 | 3-aryl-2-hydroxypropionic acid derivative I | ANDERSSON KJELL (SE) | 2003-02-06 | — | — | US | disclosed |
| US-20030018207-A1 | Phenalkyloxy-phenyl derivatives | ASTRAZENECA AB (SE) | 2003-01-23 | — | — | US | disclosed |
| EP-1237857-A1 | NEW PHENALKYLOXY-PHENYL DERIVATIVES | AstraZeneca AB (SE) | 2002-09-11 | — | — | EP | disclosed |
| US-20010034371-A1 | New 3-aryl-2-hydroxypropionic acid derivative I | ANDERSSON KJELL (SE) | 2001-10-25 | — | — | US | disclosed |
| US-6258850-B1 | SULFONATE DERIVATIVES OF ETHER, ACIDS AS DRUGS | ASTRAZENECA AB (SE) | 2001-07-10 | — | — | US | disclosed |
| WO-2001040170-A1 | NEW PHENALKYLOXY-PHENYL DERIVATIVES | ASTRAZENECA AB (SE) | 2001-06-07 | — | — | WO | disclosed |
| EP-1084102-A1 | NEW 3-ARYL PROPIONIC ACID DERIVATIVES AND ANALOGS | AstraZeneca AB (SE) | 2001-03-21 | — | — | EP | disclosed |
| EP-1084103-A1 | NEW 3-ARYL-2-HYDROXYPROPIONIC ACID DERIVATIVE (I) | AstraZeneca AB (SE) | 2001-03-21 | — | — | EP | disclosed |
| WO-1999062871-A1 | NEW 3-ARYL PROPIONIC ACID DERIVATIVES AND ANALOGS | ASTRAZENECA AB (SE) | 1999-12-09 | — | — | WO | disclosed |
| WO-1999062872-A1 | NEW 3-ARYL-2-HYDROXYPROPIONIC ACID DERIVATIVE (I) | ASTRAZENECA AB (SE) | 1999-12-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040229949-A1 | New 3-aryl propionic acid derivatives and analogs | GPR119, INSR, IRS1 | PPARA 11/4885PPARG 22/4885PPARD 8/4885 |
| US-20010034371-A1 | New 3-aryl-2-hydroxypropionic acid derivative I | GPR119, IRS1, INSR | PPARA 79/4885PPARG 144/4885PPARD 82/4885 |
| US-20040229946-A1 | New 3-aryl-2-hydroxypropionic acid derivative I | GPR119, IRS1, INSR | PPARA 79/4885PPARG 144/4885PPARD 82/4885 |
| US-20060173204-A1 | New 3-aryl propionic acid derivatives and analogs | GPR119, INSR, IRS1 | PPARA 11/4885PPARG 22/4885PPARD 8/4885 |
| US-20030027859-A1 | 3-aryl-2-hydroxypropionic acid derivative I | GPR119, IRS1, INSR | PPARA 42/4885PPARG 95/4885PPARD 64/4885 |
| US-20030018207-A1 | Phenalkyloxy-phenyl derivatives | GPR119, INSR, IAPP | PPARA 74/4885PPARG 47/4885PPARD 60/4885 |
| US-20060040979-A1 | 3-Aryl-2-hydroxypropionic acid derivative I | GPR119, IRS1, INSR | PPARA 42/4885PPARG 95/4885PPARD 64/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.